Related Experiment Videos
Neuroendocrine (HPA) and gastrointestinal effects of opiate antagonists: possible therapeutic application
M J Kreek1, J Culpepper-Morgan
1Rockefeller University, New York, New York.
NIDA Research Monograph
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol "Relapse" Drinking.
Journal of pharmaceutics & pharmacology·2022
Current status of opioid addiction treatment and related preclinical research.
Science advances·2019
Hypothalamic-specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice.
Genes, brain, and behavior·2016
Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.
Psychoneuroendocrinology·2014
Substance abuse vulnerability in offspring of alcohol and drug abusers.
NIDA research monograph·1998
Parathyroid Surgery for Primary Hyperparathyroidism in 2026.
British journal of hospital medicine (London, England : 2005)·2026
Clinical progress note: Management of the hospitalized patient with medetomidine withdrawal.
Journal of hospital medicine·2026
Practice Variation in the Pharmacologic Management of Severe Alcohol Withdrawal: a Survey of Medical Toxicology and Critical Care Physicians.
Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026